Skip to main content

Table 6 Assisted reproductive technology outcomes after PPOS ovarian stimulation considering LHCGR N312S genotype groups

From: Association of LHCGR rs2293275 genotype with ovarian aging in Chinese women: a multicenter population-based study

 

rs2293275 Medin M(P25, P75)

Kruskal-Wallis H

p

GG(n = 87)

GA(n = 20)

AA(n = 2)

AFC(bilateral)

3.000(2.0,5.0)

3.000(3.0,5.0)

5.000(4.0,6.0)

1.741

0.419

Gonadotropin injection days

9.000(7.0,11.0)

9.000(7.3,10.0)

8.000(7.0,9.0)

0.424

0.809

Total gonadotropin injections(IU)

2100.000(1275.0,2850.0)

2100.000(1237.5,2681.3)

1425.000(1200.0,1650.0)

1.086

0.581

FOI

0.500(0.3,1.0)

0.722(0.4,1.0)

0.625(0.5,0.8)

2.266

0.322

FORT

50.000(33.3,100.0)

59.921(40.0,91.7)

54.167(33.3,75.0)

0.205

0.902

OSI

1.212(0.7,2.2)

1.753(1.1,3.1)

3.587(3.5,3.6)

7.963

0.019*

Number of mature follicles before ovulation

2.000(1.0,3.0)

2.000(1.3,4.0)

2.500(2.0,3.0)

0.543

0.762

Number of retrieved oocytes

2.000(1.0,3.0)

2.500(1.0,5.0)

3.000(3.0,3.0)

2.514

0.285

MII stage oocyte

2.000(1.0,3.0)

2.000(1.0,4.0)

2.500(2.0,3.0)

1.812

0.404

MII rate

1.000(0.8,1.0)

1.000(0.7,1.0)

0.833(0.7,1.0)

1.968

0.374

High quality embryo

0.000(0.0,1.0)

1.000(0.0,1.0)

0.500(0.0,1.0)

1.417

0.492

Clinical pregnancy

0.000(0.0,0.0)

0.000(0.0,0.8)

0.000(0.0,0.0)

0.695

0.706

  1. * p < 0.05 ** p < 0.01
  2. Note: the sample size of AA group is small (n = 2), and the results should be interpreted with caution